Clearmind Medicine Inc. - Common Shares (NQ:CMND)

2.260 -0.170 (-7.00%)

Streaming Delayed Price Updated: 10:49 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	33,250
Open	2.430
Bid (Size)	2.260 (500)
Ask (Size)	2.270 (400)
Prev. Close	2.430
Today's Range	2.260 - 2.430
52wk Range	0.0661 - 3.250
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth

Today 9:15 EST

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

December 16, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Performance

YTD	+55.9%	+55.9%
1 Month	+1038.5%	+1038.5%
3 Month	+121.6%	+121.6%
6 Month	+151.5%	+151.5%
1 Year	+85.2%	+85.2%

More News

Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment

December 12, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

December 12, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2025-12-11: top gainers and losers in today's session. ↗

December 11, 2025

Via Chartmill

Top stock movements in today's session. ↗

December 11, 2025

Via Chartmill

The market is filled with gapping stocks in Thursday's session. ↗

December 11, 2025

Via Chartmill

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

December 11, 2025

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

December 10, 2025

Via Chartmill

Clearmind Medicine Announces 1-for-40 Reverse Share Split

December 10, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

December 05, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Which stocks are gapping on Wednesday? ↗

December 03, 2025

Via Chartmill

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

December 03, 2025

Via Chartmill

Curious about the most active stocks on Tuesday? ↗

December 02, 2025

Via Chartmill

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder

December 02, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial

December 01, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial

November 25, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

November 24, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

November 20, 2025

From SciSparc Ltd

Via GlobeNewswire

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

November 20, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tuesday's after hours session: top gainers and losers ↗

November 18, 2025

Via Chartmill

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

November 18, 2025

Via Chartmill

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

November 18, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

On Monday, there are stocks with unusual volume. Let's take a look. ↗

November 17, 2025

Via Chartmill

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

November 17, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Clearmind Medicine Inc. - Common Shares publicly traded?

Yes, Clearmind Medicine Inc. - Common Shares is publicly traded.

What exchange does Clearmind Medicine Inc. - Common Shares trade on?

Clearmind Medicine Inc. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Clearmind Medicine Inc. - Common Shares?

The ticker symbol for Clearmind Medicine Inc. - Common Shares is CMND on the Nasdaq Stock Market

What is the current price of Clearmind Medicine Inc. - Common Shares?

The current price of Clearmind Medicine Inc. - Common Shares is 2.260

When was Clearmind Medicine Inc. - Common Shares last traded?

The last trade of Clearmind Medicine Inc. - Common Shares was at 12/24/25 10:49 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.